Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 153 No. 3 (2023)

Faecal calprotectin increases the diagnostic yield in patients with suspected small bowel disease – a multicenter retrospective cohort study

  • Aisha Abo El Ela
  • Nina Meuli
  • Petr Hruz
  • Emanuel Burri
DOI
https://doi.org/10.57187/smw.2023.40050
Cite this as:
Swiss Med Wkly. 2023;153:40050
Published
22.03.2023

Summary

AIM OF THE STUDY: Diagnosing small bowel pathology is challenging, and the diagnostic yield of small bowel capsule endoscopy is highly variable. Faecal calprotectin is a non-invasive intestinal inflammation marker that could be used as a selection tool to identify patients who might benefit from small bowel capsule endoscopy and increase its diagnostic yield. This study aimed to investigate the value of faecal calprotectin in detecting small bowel lesions in an unselected patient population.

METHODS: We performed a retrospective analysis of consecutive patients who underwent small bowel capsule endoscopy at the University Hospital Basel and the University Medical Clinic Cantonal Hospital Baselland, Switzerland, between 2010 and 2018. Patients without faecal calprotectin testing were excluded from the analysis. The primary endpoint was the presence of a clinically significant small bowel finding.

RESULTS: Patients with positive faecal calprotectin results were more likely to have small bowel findings (66.7% vs 39.4%; P = 0.007). The optimal faecal calprotectin cut-off to identify clinically significant small bowel lesions was 63 μg/g with 78.3% (95% confidence interval: 66.7–87.9) sensitivity, 47.9% (33.3–62.8) specificity, 1.50 (1.1–2.0) positive and 0.45 (0.3–0.8) negative likelihood ratios, 68.4% (61.6–74.4) positive and 60.5% (47.3–72.4) negative predictive values, and 65.0% overall accuracy. Faecal calprotectin performed best in patients with suspected inflammatory bowel disease, with 66.7% (48.2–82.0) sensitivity, 70.6% (44.0–89.7) specificity, 2.27 (1.0–4.9) positive and 0.47 (0.3–0.8) negative likelihood ratios, 81.5% (67.0–90.5) positive and 54.5% (39.7–68.6) negative predictive values, and 71.4% overall accuracy.

CONCLUSION: Faecal calprotectin testing increases the diagnostic yield of small bowel capsule endoscopy and may help identify patients at risk of small bowel disease.

References

  1. Gerson LB , Fidler JL , Cave DR , Leighton JA . ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroenterol. 2015 Sep;110(9):1265–87. https://doi.org/10.1038/ajg.2015.246 DOI: https://doi.org/10.1038/ajg.2015.246
  2. Pennazio M , Spada C , Eliakim R , Keuchel M , May A , Mulder CJ , et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2015 Apr;47(4):352–76. https://doi.org/10.1055/s-0034-1391855 DOI: https://doi.org/10.1055/s-0034-1391855
  3. Samuel S , Bruining DH , Loftus EV Jr , Becker B , Fletcher JG , Mandrekar JN , et al. Endoscopic skipping of the distal terminal ileum in Crohn’s disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol. 2012 Nov;10(11):1253–9. https://doi.org/10.1016/j.cgh.2012.03.026 DOI: https://doi.org/10.1016/j.cgh.2012.03.026
  4. Van Assche G , Dignass A , Panes J , Beaugerie L , Karagiannis J , Allez M , et al.; European Crohn’s and Colitis Organisation (ECCO) . The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohn’s Colitis. 2010 Feb;4(1):7–27. https://doi.org/10.1016/j.crohns.2009.12.003 DOI: https://doi.org/10.1016/j.crohns.2009.12.003
  5. Gomollón F , Dignass A , Annese V , Tilg H , Van Assche G , Lindsay JO , et al.; ECCO . 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohn’s Colitis. 2017 Jan;11(1):3–25. https://doi.org/10.1093/ecco-jcc/jjw168 DOI: https://doi.org/10.1093/ecco-jcc/jjw168
  6. Vavricka SR , Spigaglia SM , Rogler G , Pittet V , Michetti P , Felley C , et al.; Swiss IBD Cohort Study Group . Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012 Mar;18(3):496–505. https://doi.org/10.1002/ibd.21719 DOI: https://doi.org/10.1002/ibd.21719
  7. Enns RA , Hookey L , Armstrong D , Bernstein CN , Heitman SJ , Teshima C , et al.; Clinical Practice Guidelines for the Use of Video Capsule Endoscopy . Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology. 2017 Feb;152(3):497–514. https://doi.org/10.1053/j.gastro.2016.12.032 DOI: https://doi.org/10.1053/j.gastro.2016.12.032
  8. Luján-Sanchis M , Sanchis-Artero L , Larrey-Ruiz L , Peño-Muñoz L , Núñez-Martínez P , Castillo-López G , et al. Current role of capsule endoscopy in Crohn’s disease. World J Gastrointest Endosc. 2016 Sep;8(17):572–83. https://doi.org/10.4253/wjge.v8.i17.572 DOI: https://doi.org/10.4253/wjge.v8.i17.572
  9. Xue M , Chen X , Shi L , Si J , Wang L , Chen S . Small-bowel capsule endoscopy in patients with unexplained chronic abdominal pain: a systematic review. Gastrointest Endosc. 2015 Jan;81(1):186–93. https://doi.org/10.1016/j.gie.2014.04.062 DOI: https://doi.org/10.1016/j.gie.2014.04.062
  10. Teshima CW , Kuipers EJ , van Zanten SV , Mensink PB . Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol. 2011 May;26(5):796–801. https://doi.org/10.1111/j.1440-1746.2010.06530.x DOI: https://doi.org/10.1111/j.1440-1746.2010.06530.x
  11. Lim YJ , Lee OY , Jeen YT , Lim CY , Cheung DY , Cheon JH , et al.; Korean Gut Image Study Group . Indications for Detection, Completion, and Retention Rates of Small Bowel Capsule Endoscopy Based on the 10-Year Data from the Korean Capsule Endoscopy Registry. Clin Endosc. 2015 Sep;48(5):399–404. https://doi.org/10.5946/ce.2015.48.5.399 DOI: https://doi.org/10.5946/ce.2015.48.5.399
  12. Koulaouzidis A , Rondonotti E , Giannakou A , Plevris JN . Diagnostic yield of small-bowel capsule endoscopy in patients with iron-deficiency anemia: a systematic review. Gastrointest Endosc. 2012 Nov;76(5):983–92. https://doi.org/10.1016/j.gie.2012.07.035 DOI: https://doi.org/10.1016/j.gie.2012.07.035
  13. Yung DE , Rondonotti E , Giannakou A , Avni T , Rosa B , Toth E , et al.; And the Capsule Endoscopy in Young Patients with IDA research group . Capsule endoscopy in young patients with iron deficiency anaemia and negative bidirectional gastrointestinal endoscopy. United European Gastroenterol J. 2017 Nov;5(7):974–81. https://doi.org/10.1177/2050640617692501 DOI: https://doi.org/10.1177/2050640617692501
  14. Olano C , Pazos X , Avendaño K , Calleri A , Ketzoian C . Diagnostic yield and predictive factors of findings in small-bowel capsule endoscopy in the setting of iron-deficiency anemia. Endosc Int Open. 2018 Jun;6(6):E688–93. https://doi.org/10.1055/a-0593-5915 DOI: https://doi.org/10.1055/a-0593-5915
  15. Choi M , Lim S , Choi MG , Shim KN , Lee SH . Effectiveness of Capsule Endoscopy Compared with Other Diagnostic Modalities in Patients with Small Bowel Crohn’s Disease: A Meta-Analysis. Gut Liver. 2017 Jan;11(1):62–72. https://doi.org/10.5009/gnl16015 DOI: https://doi.org/10.5009/gnl16015
  16. Carter D , Katz LH , Bardan E , Salomon E , Goldstein S , Ben Horin S , et al. The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy. Therap Adv Gastroenterol. 2018 Apr;11:1756284818765908. https://doi.org/10.1177/1756284818765908 DOI: https://doi.org/10.1177/1756284818765908
  17. Goldstein JL , Eisen GM , Lewis B , Gralnek IM , Aisenberg J , Bhadra P , et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther. 2007 May;25(10):1211–22. https://doi.org/10.1111/j.1365-2036.2007.03312.x DOI: https://doi.org/10.1111/j.1365-2036.2007.03312.x
  18. Maiden L , Thjodleifsson B , Theodors A , Gonzalez J , Bjarnason I . A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005 May;128(5):1172–8. https://doi.org/10.1053/j.gastro.2005.03.020 DOI: https://doi.org/10.1053/j.gastro.2005.03.020
  19. Shimoyama T , Yamamoto T , Umegae S , Matsumoto K . Faecal biomarkers for screening small bowel inflammation in patients with Crohn’s disease: a prospective study. Therap Adv Gastroenterol. 2017 Aug;10(8):577–87. https://doi.org/10.1177/1756283X17717683 DOI: https://doi.org/10.1177/1756283X17717683
  20. Monteiro S , Barbosa M , Cúrdia Gonçalves T , Boal Carvalho P , Moreira MJ , Rosa B , et al. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn’s Disease. Inflamm Bowel Dis. 2018 Aug;24(9):2033–8. https://doi.org/10.1093/ibd/izy098
  21. Egea Valenzuela J , Pereñíguez López A , Pérez Fernández V , Alberca de Las Parras F , Carballo Álvarez F . Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn’s disease. Rev Esp Enferm Dig. 2016 Jul;108(7):394–400. DOI: https://doi.org/10.17235/reed.2016.4318/2016
  22. Jensen MD , Kjeldsen J , Nathan T . Fecal calprotectin is equally sensitive in Crohn’s disease affecting the small bowel and colon. Scand J Gastroenterol. 2011 Jun;46(6):694–700. https://doi.org/10.3109/00365521.2011.560680 DOI: https://doi.org/10.3109/00365521.2011.560680
  23. Kopylov U , Yung DE , Engel T , Avni T , Battat R , Ben-Horin S , et al. Fecal calprotectin for the prediction of small-bowel Crohn’s disease by capsule endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1137–44. https://doi.org/10.1097/MEG.0000000000000692 DOI: https://doi.org/10.1097/MEG.0000000000000692
  24. Koulaouzidis A , Douglas S , Rogers MA , Arnott ID , Plevris JN . Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scand J Gastroenterol. 2011 May;46(5):561–6. https://doi.org/10.3109/00365521.2011.551835 DOI: https://doi.org/10.3109/00365521.2011.551835
  25. Yablecovitch D , et al. The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease? Therap Adv Gastroenterol, 2018. 11: p. 1756283X17747780. DOI: https://doi.org/10.1177/1756283X17747780
  26. Koulaouzidis A , Sipponen T , Nemeth A , Makins R , Kopylov U , Nadler M , et al. Association Between Fecal Calprotectin Levels and Small-bowel Inflammation Score in Capsule Endoscopy: A Multicenter Retrospective Study. Dig Dis Sci. 2016 Jul;61(7):2033–40. https://doi.org/10.1007/s10620-016-4104-7 DOI: https://doi.org/10.1007/s10620-016-4104-7
  27. Koulaouzidis A , Nemeth A , Johansson GW , Toth E . Dissecting Lewis score under the light of fecal calprotectin; an analysis of correlation of score components with calprotectin levels in capsule endoscopy. Ann Gastroenterol. 2015;28(2):259–64.
  28. Sipponen T , Haapamäki J , Savilahti E , Alfthan H , Hämäläinen E , Rautiainen H , et al. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn’s disease detected by wireless capsule endoscopy. Scand J Gastroenterol. 2012 Jul;47(7):778–84. https://doi.org/10.3109/00365521.2012.677953 DOI: https://doi.org/10.3109/00365521.2012.677953
  29. Hale MF , Drew K , McAlindon ME , Sidhu R . The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn’s disease. Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1145–50. https://doi.org/10.1097/MEG.0000000000000696 DOI: https://doi.org/10.1097/MEG.0000000000000696
  30. Olsen PA , Fossmark R , Qvigstad G . Fecal calprotectin in patients with suspected small bowel disease—a selection tool for small bowel capsule endoscopy? Scand J Gastroenterol. 2015 Mar;50(3):272–7. https://doi.org/10.3109/00365521.2014.1003395 DOI: https://doi.org/10.3109/00365521.2014.1003395
  31. Yousuf H , Aleem U , Egan R , Maheshwari P , Mohamad J , McNamara D . Elevated Faecal Calprotectin Levels are a Reliable Non-Invasive Screening Tool for Small Bowel Crohn’s Disease in Patients Undergoing Capsule Endoscopy. Dig Dis. 2018;36(3):202–8. https://doi.org/10.1159/000485375 DOI: https://doi.org/10.1159/000485375
  32. Zittan E , Kelly OB , Gralnek IM , Silverberg MS , Hillary Steinhart A . Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn’s disease activity. JGH Open. 2018 Jul;2(5):201–6. https://doi.org/10.1002/jgh3.12068 DOI: https://doi.org/10.1002/jgh3.12068
  33. Lasson A , Stotzer PO , Öhman L , Isaksson S , Sapnara M , Strid H . The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J Crohn’s Colitis. 2015 Jan;9(1):26–32. DOI: https://doi.org/10.1016/j.crohns.2014.06.002
  34. Schoepfer AM , Dehlavi MA , Fournier N , Safroneeva E , Straumann A , Pittet V , et al.; IBD Cohort Study Group . Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013 Nov;108(11):1744–53. https://doi.org/10.1038/ajg.2013.248 DOI: https://doi.org/10.1038/ajg.2013.248
  35. Gisbert JP , McNicholl AG . Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis. 2009 Jan;41(1):56–66. https://doi.org/10.1016/j.dld.2008.05.008 DOI: https://doi.org/10.1016/j.dld.2008.05.008
  36. von Roon AC , Karamountzos L , Purkayastha S , Reese GE , Darzi AW , Teare JP , et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007 Apr;102(4):803–13. https://doi.org/10.1111/j.1572-0241.2007.01126.x DOI: https://doi.org/10.1111/j.1572-0241.2007.01126.x
  37. van Rheenen PF , Van de Vijver E , Fidler V . Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010 Jul;341 jul15 1:c3369. https://doi.org/10.1136/bmj.c3369 DOI: https://doi.org/10.1136/bmj.c3369
  38. D’Angelo F , Felley C , Frossard JL . Calprotectin in Daily Practice: Where Do We Stand in 2017? Digestion. 2017;95(4):293–301. https://doi.org/10.1159/000476062 DOI: https://doi.org/10.1159/000476062
  39. Freeman K , Ryan R , Parsons N , Taylor-Phillips S , Willis BH , Clarke A . Faecal calprotectin testing in UK general practice: a retrospective cohort study using The Health Improvement Network database. Br J Gen Pract. 2021 Oct;71(712):e854–61. https://doi.org/10.3399/BJGP.2021.0125 DOI: https://doi.org/10.3399/BJGP.2021.0125
  40. Monteiro S , Barbosa M , Cúrdia Gonçalves T , Boal Carvalho P , Moreira MJ , Rosa B , et al. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn’s Disease. Inflamm Bowel Dis. 2018 Aug;24(9):2033–8. https://doi.org/10.1093/ibd/izy098 DOI: https://doi.org/10.1093/ibd/izy098
  41. Conroy S , Hale MF , Cross SS , Swallow K , Sidhu RH , Sargur R , et al. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care. J Clin Pathol. 2018 Apr;71(4):316–22. https://doi.org/10.1136/jclinpath-2017-204506 DOI: https://doi.org/10.1136/jclinpath-2017-204506

Most read articles by the same author(s)